Holen Sie sich die Stockscreener-App
5.69
4.53%
-0.27
Handel nachbörslich:
5.55
-0.14
-2.46%
Cybin Inc Aktie (CYBN) Neueste Nachrichten
Cybin to Participate in Cowen’s Psychedelics & Novel Mechanisms in Neuropsychiatry Virtual Summit on July 13th - Business Wire
(CYBN) Investment Analysis and Advice - news.stocktradersdaily.com
Guggenheim Initiates Coverage of Cybin (CYBN) with Buy Recommendation - Nasdaq
Cybin wins new Buy from Guggenheim: potential to challenge J&J’s Spravato cited - Seeking Alpha
Cybin initiated with a Buy at Guggenheim - TipRanks
Cybin Inc. Reports Q3 2025 Financial Results and Strategic Progress - TipRanks
Psychedelic Science 2025 Announces Select Speakers for the Leading Conference on Psychedelic Research, Policy, and Thought Leadership - GlobeNewswire Inc.
Cybin Inc. (CYBN) Loses -25.81% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Nasdaq
Cybin Inc. (CYBN): Among the Best Psychedelic Stocks to Buy in 2025 - Insider Monkey
12 Best Psychedelic Stocks to Buy in 2025 - Insider Monkey
Wall Street Analysts Think Cybin Inc. (CYBN) Could Surge 988.67%: Read This Before Placing a Bet - MSN
Cybin (OTCMKTS:CLXPF) Shares Down 2.5%Here's What Happened - MarketBeat
How to Take Advantage of moves in (CYBN) - news.stocktradersdaily.com
Revolutionizing Mental Health Through Psychedelic Therapeutics | by Dr. Gleb Tsipursky | Feb, 2025 - DataDrivenInvestor
Cybin (NYSE:CYBN) Price Target Cut to $150.00 by Analysts at HC Wainwright - MarketBeat
Cybin (OTCMKTS:CYBN) Trading Up 1.2%Here's Why - MarketBeat
Canaccord cuts Cybin stock target to $73, maintains Buy rating - MSN
Cybin (NYSE:CYBN) Price Target Lowered to $73.00 at Canaccord Genuity Group - MarketBeat
Cybin stock price target cut to $150 at H.C. Wainwright - MSN
Cybin stock price target cut to $150 at H.C. Wainwright By Investing.com - Investing.com Australia
Canaccord cuts Cybin stock target to $73, maintains Buy rating By Investing.com - Investing.com Nigeria
(CYBN) Investment Analysis - Stock Traders Daily
Cybin sees third-quarter loss on R&D costs, advances clinical programs - Green Market Report
Cybin Accelerates PARADIGM Program for Depression Treatment - TipRanks
Cybin's Depression Drug Shows Perfect Response Rate, Advances to Pivotal Phase 3 with C$136M War Chest - StockTitan
Upstart (UPST) Reports Earnings Tomorrow: What To Expect - The Globe and Mail
Cybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights - Business Wire
Trade thoughts for Gold futures - The Globe and Mail
Is Rigetti Computing a Millionaire-Maker Stock? - The Globe and Mail
HC Wainwright Forecasts Cybin's Q3 Earnings (NYSE:CYBN) - MarketBeat
What is HC Wainwright's Estimate for Cybin FY2029 Earnings? - MarketBeat
Cybin (OTCMKTS:CLXPF) Shares Up 1.9%What's Next? - MarketBeat
What is HC Wainwright's Forecast for Cybin FY2029 Earnings? - MarketBeat
How To Trade (CYBN) - Stock Traders Daily
HC Wainwright Issues Optimistic Estimate for Cybin Earnings - Defense World
10.70%
Kapitalisierung:
|
Volumen (24h):